Vimarsana
Biggest News Aggregation in the World

Page 41 - Sofinnova Partners News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sofinnova Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sofinnova Partners Today - Breaking & Trending Today

Inspirna Raises $50M in Series D Financing - Vimarsana News

Inspirna Raises $50M in Series D Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

DGAP-News: SafeHeal Appoints Medical Device Industry Veteran Chris Richardson as Chief Executive Officer Seite 1 - Vimarsana News

DGAP-News: SafeHeal Appoints Medical Device Industry Veteran Chris Richardson as Chief Executive Officer Seite 1

11.07.2022 - DGAP-News: SafeHeal / Key word(s): Personnel SafeHeal Appoints Medical Device Industry Veteran Chris Richardson as Chief Executive Officer 11.07.2022 / 15:00 The issuer is solely responsible for the content of this announcement. SafeHeal Appoints ... Seite 1

Biosyntia Closes EUR11.5M Funding Round - Vimarsana News

Biosyntia Closes EUR11.5M Funding Round

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

DGAP-News: Sofinnova Partners: AAVantgarde Announces the Appointment of Naveed Shams, M.D., Ph.D. as Chief Development and Medical Officer - Vimarsana News

DGAP-News: Sofinnova Partners: AAVantgarde Announces the Appointment of Naveed Shams, M.D., Ph.D. as Chief Development and Medical Officer

DGAP-News: Sofinnova Partners / Key word(s): Personnel Sofinnova Partners: AAVantgarde Announces the Appointment of Naveed Shams, M.D., Ph.D. as Chief Development and Medical Officer 30.06.2022 / 08:00 The issuer is solely responsible for the content of this announcement. AAVantgarde Announces t...

Inspirna, Inc.: Inspirna to Present Phase 1b RGX-202-01 Clinical Trial Data at the 2022 ESMO World Congress on Gastrointestinal Cancer - Vimarsana News

Inspirna, Inc.: Inspirna to Present Phase 1b RGX-202-01 Clinical Trial Data at the 2022 ESMO World Congress on Gastrointestinal Cancer

Favorable efficacy and safety support further development of RGX-202-01 in advanced or metastatic second-line colorectal cancer Inspirna, Inc., a clinical stage biopharmaceutical company developing